[1]Havelka GE, Kibbe MR. The vascular adventitia: its role in the arterial injury response[J].Vasc Endovascular Surg,2011, 45(5): 381-390.
[2]Panza JA, Casino PR,Kilcoyne CM,et al. Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension[J]. Circulation,1993,87(50):1468-1474.
[3]Liu J, Ormsby A, Oja-Tebbe N,et al. Gene transfer of NAD(P)H oxidase inhibitor to the vascular adventitia attenuates medial smooth muscle hypertrophy[J]. Circ Res, 2004,95(6): 587-594.
[4]Herrmann J, Samee S, Chade A, et al. Differential effect of experimental hypertension and hypercholesterolemia on adventitial remodeling[J]. Arterioscler Thromb Vasc Biol, 2005, 25(2): 447-453.
[5]Birukov KG. Cyclic stretch, reactive oxygen species, and vascular remodeling[J]. Antioxid Redox Signa, 2009,11(7):1651-1667.
[6]Maiellaro K, Taylor WR. The role of the adventitia in vascular inflammation[J]. Cardiovasc Res, 2007,75(4):640-648.
[7]Barnes L, Gorin Y. Myofibroblast differentiation during fibrosis: role of NAD(P)H oxidases[J]. Kidney Int, 2011, 79(9): 944-956.
[8]Csanyi G, Taylor WR, Pagano PJ. NOX and inammation in the vascular adventitia[J]. Free Radic Biol Med, 2009, 47(9): 1254-1266.
[9]Wang HX, Yang H, Han QY, et al. NADPH oxidases mediate a cellular “memory” of angiotensin Ⅱ stress in hypertensive cardiac hypertrophy[J]. Free Radic Biol Med, 2013,65:897-907.[10]Savoia C, Burger D, Nishigaki N, et al. Angiotensin Ⅱ and the vascular phenotype in hypertension[J]. Expert Rev Mol Med, 2011,13:e11.
[11]Weaver M, Liu J, Pimentel D, et al. Adventitial delivery of dominant-negative p67phox attenuates neointimal hyperplasia of the rat carotid artery[J]. Am J Physiol Heart Circ Physiol, 2006,290(5):H1933-1941.
[12]Cascino T, Csanyi G, Al Ghouleh I, et al. Adventitia-derived hydrogen peroxide impairs relaxation of the rat carotid artery via smooth muscle cell p38 mitogen-activated protein kinase[J]. Antioxid Redox Signal,2011, 15(6): 1507-1515.
[13]Sumners C, Fleegal MA, Zhu M. Angiotensin ATl receptor signailing pathways in neurons[J]. Clin Exp Pharmacol Physiol, 2002, 29(5-6): 483-490.
[14]Lob HE, Schultz D, Marvar PJ, et al. Role of the NADPH oxidases in the subfornical organ in angiotensin Ⅱ-induced hypertension[J]. Hypertension, 2013,61(2):382-387. |